Ledger.Open graph →
SEC Form D · filed June 24, 2019

AXIAL BIOTHERAPEUTICS, INC

Offering
$10.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WALTHAM, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Sarkis K. Mazmanian · WALTHAM, MADirectorEric C. De La Fortelle · WALTHAM, MADirectorDavid H. Donabedian · WALTHAM, MAExec · DirectorJames C. Blair · WALTHAM, MADirectorSakae C. Asanuma · WALTHAM, MADirectorHenry C. Wolf · WALTHAM, MADirectorRonald C. Renaud Jr · WALTHAM, MADirectorRichard P. Aldrich · WALTHAM, MADirectorJeffrey C. Young · WALTHAM, MAExecStephanie Dominy · Reading, United KingdomDirectorJanine Yorio · New York, NYDirectorPhilippe Botteri · Reading, United KingdomExec · DirectorMatthew Weigand · Reading, United KingdomDirectorJesse Stein · New York, NYExecGuy Podjarny · Reading, United KingdomDirectorKen Fox · Reading, United KingdomDirectorJeffrey P. Anstis · Jacksonville, FLDirectorPeter Mckay · Reading, United KingdomDirectorWilliam W. Grantham · Charlotte, NCExecJack W. Apgar · Charlotte, NCDirectorAure Bruneau · Pompano Beach, FLDirectorRcp Advisors 2, LLC · CHICAGO, ILExec · DirectorSimeon George · Conshohocken, PADirectorRajeev Dadoo · Conshohocken, PADirectorAndrew Kruegel · New York, NYDirectorJonathan Sporn · New York, NYDirectorJed N. Katz · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗